Misoprostol Now Included on Nigeria’s Essential Drug List
April 28, 2011 | From the field | Population & Reproductive Health

Nigeria's Federal Ministry of Health has approved the inclusion of misoprostol on the Essential Drug List (EDL). Misoprostol is used for the prevention and treatment of postpartum hemorrhage, a leading cause of maternal mortality. Its inclusion on the EDL, which gives the drug the status of national priority, follows a MacArthur-supported research report on community-based use of the drug conducted by Dr. Clara Ejembi at Ahmadu Bello University in Zaria.

Stay Informed
Sign up for periodic news updates and event invitations. Check out our social media content in one place, or connect with us on Twitter, Facebook, YouTube, and LinkedIn.